10-Q quarterly report · filed Nov 2, 2026

Tempus AI Inc (TEM) Q3 2026 10-Q Quarterly Report

Short answer

Tempus AI Inc (TEM) filed its Q3 2026 10-Q quarterly report on Nov 2, 2026 for the quarter ended Sep 30, 2026. Quarterly revenue was $412M (up 23.1% year over year) with net income of −$15M.

Q3 2026 key financials · XBRL

Revenue
$412M
+23.1% YoY · +7.6% QoQ
Net income
−$15M
+81.4% YoY · −363.2% QoQ
Operating margin
-13.8%
EPS (diluted)
−$0.08
+82.6% YoY · −300.0% QoQ

Source: XBRL data from the Tempus AI Inc (TEM) Q3 2026 10-Q on SEC EDGAR. USD.

Tempus AI Inc Q3 2026 10-Q analysis

AI summary of MD&A and risk factor updates

Management Discussion & Analysis

  • Quarterly revenue $411.5M, up $77.3M from $334.2M YoY
  • Diagnostics revenue $303.5M vs $252.9M, strongest segment, driven by oncology testing
  • Data and applications revenue $108.1M vs $81.3M, increased Insights and Next demand
  • Net loss $14.9M vs $80.0M, adjusted EBITDA $25.6M vs $1.5M
  • Cash, equivalents and restricted cash $595.2M; operating cash use $71.6M, 2032 Notes proceeds $443.1M
  • Near-term losses expected, with higher expenses for offerings, sales expansion and marketing; tariffs may raise technology costs

Risk Factors

  • New acquisition risk: Proposed Personalis deal may terminate if not completed by April 20, 2027, potentially triggering a $76.8 million fee
  • Regulatory risk: Acquisition requires Personalis stockholder approval, regulatory clearances, and Nasdaq listing approval
  • Operational risk: Integration may disrupt operations through employee, client, vendor, and service-provider losses
  • Financial risk: Convertible Notes total $1.21 billion, with cash conversion potentially reducing liquidity
  • Market risk: Failed acquisition could negatively affect Class A share price and results of operations

Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K

Ask about this quarter

Compare quarters, check guidance or see what insiders and funds did around the report.